 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
Date |
Open |
High |
Low |
Close |
Volume |
02/06/2025 |
$10.18 |
$10.18 |
$10.18 |
$10.18 |
100 | 02/07/2025 |
$10.15 |
$10.16 |
$10.15 |
$10.15 |
500 | 02/10/2025 |
$10.15 |
$10.16 |
$10.15 |
$10.16 |
100 | 02/11/2025 |
$10.14 |
$10.15 |
$10.14 |
$10.15 |
700 | 02/12/2025 |
$10.12 |
$10.12 |
$10.12 |
$10.12 |
100 |
 |
Gentium is a biopharmaceutical company focused on the development and manufacture of Co.'s primary product candidate, defibrotide, an investigational drug based on single-stranded DNA extracted from pig intestines. Co.'s development of defibrotide has been focused on the treatment and prevention of a disease VOD, a condition in which some of the veins in the liver are blocked as a result of cancer treatments, such as chemotherapy or radiation treatments, that are given prior to stem cell transplantation. Severe VOD is the most extreme form of VOD and is associated with multiple-organ failure and high rates of morbidity and mortality. | |
 |

Spinnaker Etf Series Genter Capital Taxable Qualit (GENT) has the following price history information. Looking back at GENT historical stock prices for the last five trading days, on February 06, 2025, GENT opened at $10.18, traded as high as $10.18 and as low as $10.18, and closed at $10.18. Trading volume was a total of 100 shares. On February 07, 2025, GENT opened at $10.15, traded as high as $10.16 and as low as $10.15, and closed at $10.15. Trading volume was a total of 500 shares. On February 10, 2025, GENT opened at $10.15, traded as high as $10.16 and as low as $10.15, and closed at $10.16. Trading volume was a total of 100 shares. On February 11, 2025, GENT opened at $10.14, traded as high as $10.15 and as low as $10.14, and closed at $10.15. Trading volume was a total of 700 shares. On February 12, 2025, GENT opened at $10.12, traded as high as $10.12 and as low as $10.12, and closed at $10.12. Trading volume was a total of 100 shares.
GENT Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Spinnaker Etf Series Genter Capital Taxable Qualit shares, starting with a $10,000 purchase of GENT, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
05/23/2024 |
|
End date: |
02/12/2025 |
|
Start price/share: |
$10.05 |
|
End price/share: |
$10.12 |
|
Starting shares: |
995.02 |
|
Ending shares: |
1,019.96 |
|
Dividends reinvested/share: |
$0.25 |
|
Total return: |
3.17% |
|
Annualized Gain: |
4.36% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$10,317.00 |
|
Years: |
0.73 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/23/2024 |
|
End date: |
02/12/2025 |
|
Start price/share: |
$10.05 |
|
End price/share: |
$10.12 |
|
Dividends collected/share: |
$0.25 |
|
Total return: |
3.17% |
|
Annualized Gain: |
4.37% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$10,317.00 |
|
Years: |
0.73 |
|
|
 |
Date |
Close |
02/06/2025 | $10.18 | 02/07/2025 | $10.15 | 02/10/2025 | $10.16 | 02/11/2025 | $10.15 | 02/12/2025 | $10.12 |
|
 |